Clinical Trials Directory

Trials / Unknown

UnknownNCT01787630

To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy

Initiating Phase II-III Study to Evaluate the Technique and Effects of Separating the Prostate From the Rectum With Hyaluronic Acid During Radiotherapy

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Anders Widmark · Academic / Other
Sex
Male
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The dominating problem after local radiotherapy of prostate cancer is rectal toxicity. If the rectum could be completely moved out of the treated volume, a substantial decrease of rectal toxicity seems reasonable. In this study we will develop and evaluate a new transrectal injection technique where hyaluronic acid (HA) is injected in the space between the prostate and the rectum prior to external beam radiotherapy to increase the physical distance between prostate and rectum.

Conditions

Interventions

TypeNameDescription
DEVICEHyaluronic acidInjection in connection with ultrasound

Timeline

Start date
2010-01-01
Primary completion
2016-03-01
Completion
2021-03-01
First posted
2013-02-08
Last updated
2016-11-04

Locations

3 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01787630. Inclusion in this directory is not an endorsement.

To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy (NCT01787630) · Clinical Trials Directory